相关实验视频
Updated: May 12, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
2024年CVOT峰会报告:新的心血管,脏和代谢结果
Oliver Schnell1, Jaime Almandoz2, Lisa Anderson3,4
1Forschergruppe Diabetes e. V., Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Neuherberg (Munich), Germany. oliver.schnell@lrz.uni-muenchen.de.
Cardiovascular diabetology
|May 2, 2025
概括
第十届心血管结果试验峰会强调了关于empagliflozin,semaglutide,tirzepatide和finerenone的新发现. 这些试验有望减少心血管和事件,改善心力衰竭和慢性病等疾病的代谢健康.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 第十届心血管结果试验 (CVOT) 峰会召开,讨论心血管,脏和代谢结果的关键进展.
- 焦点领域包括最近对影响重大心血管不良事件 (MACE) 和代谢健康的关键治疗剂的试验数据.
研究的目的:
- 审查和传播主要心血管,脏和代谢结局试验的最新发现.
- 讨论心脏-脏-代谢 (CKM) 综合征管理中的新和成熟的疗法,指导方针和新兴概念.
主要方法:
- 大会的重点是讨论临床试验数据,包括empagliflozin (EMPACT-MI),semaglutide (STEP-HFpEF-DM,FLOW),tirezepatide (SURMOUNT-OSA,SUMMIT) 和finerenone (FINEARTS-HF). 会议的讨论主要集中在临床试验数据上,包括empagliflozin (EMPACT-MI),semaglutide (STEP-HFpEF-DM,FLOW),tirezepatide (SURMOUNT-OSA,SUMMIT) 和finerenone (FINEARTS-HF) 在内的临床试验数据.
- 会议涵盖了治疗策略,临床指南,器官交叉通话,精准医学,糖尿病管理和初级保健在CKM疾病中的作用.
主要成果:
- 在降低MACE和改善心力衰竭与保存喷射分数 (HFpEF),慢性病 (CKD) 和阻塞性睡眠呼吸暂停 (OSA) 的结果方面取得了重大进展.
- 突出了对隐形蛋白疗法的新兴理解,环境塑料污染对心血管疾病风险的影响以及营养策略.
结论:
- 峰会强调了最近的试验对管理复杂的心脏,脏和代谢疾病的转变性影响.
- 持续的研究和跨学科的合作对于推进CKM疾病的患者护理至关重要.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
69
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
69
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
01:23Assessment of the Cardiovascular System I: Subjective Data
243
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
243
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
01:27Regulation of the Cardiovascular System
259
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
259
01:17Imaging Studies for Cardiovascular System I:Echocardiography
267
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
267